rigid amphipathic fusion inhibitors (University of Alberta)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namerigid amphipathic fusion inhibitors (University of Alberta)
Drug Alias NameaUY11ddUY11aY12PuddU11dUUY11 +[9] 
ClassificationSmall molecules
Mechanisms of ActionEnvelope glycoprotein inhibitors
TargetsEnvelope glycoprotein
Therapy Area/IndicationsHepatitis CVirus Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Alberta
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Alberta
Active IndicationsN/A
Inactive IndicationsHepatitis CVirus Diseases

Other Information

ATC CodeN/A
Related LinksN/A